Galapagos NV
GLPG
#4880
Rank
S$2.47 B
Marketcap
S$36.83
Share price
-1.03%
Change (1 day)
11.58%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: S$2.47 Billion

As of April 2026 Galapagos NV has a market cap of S$2.47 Billion. This makes Galapagos NV the world's 4880th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.47 B-11.49%
2025S$2.79 B14.28%
2024S$2.44 B-30.88%
2023S$3.53 B-9.68%
2022S$3.91 B-20.69%
2021S$4.93 B-42.35%
2020S$8.56 B-52.97%
2019S$18.21 B165.62%
2018S$6.85 B6.75%
2017S$6.42 B48.94%
2016S$4.31 B23.69%
2015S$3.48 B362.39%
2014S$0.75 B-5.03%
2013S$0.79 B14.9%
2012S$0.69 B49.61%
2011S$0.46 B-15.71%
2010S$0.54 B53.14%
2009S$0.35 B143.5%
2008S$0.14 B

End of Day market cap according to different sources

On Apr 22nd, 2026 the market cap of Galapagos NV was reported to be:

S$2.45 Billion
by Nasdaq info icon info icon
S$2.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$705.52 B 28,425.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$202.72 B 8,096.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$454.94 B 18,293.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$145.78 B 5,794.15%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$359.84 B 14,448.74%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$387.62 B 15,571.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$143.94 B 5,719.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
S$92.73 M-96.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$47.06 B 1,802.91%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel